Actelion Pharmaceuticals Ltd - Company Profile
Powered by 
All the data and insights you need on Actelion Pharmaceuticals Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Actelion Pharmaceuticals Ltd Strategy Report
- Understand Actelion Pharmaceuticals Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
The following section provides information on Actelion Pharmaceuticals Ltd’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Actelion Pharmaceuticals Ltd's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Andre C. Muller
Executive Vice President; Chief Financial Officer Senior ManagementMr. Andre C. Muller has been the Chief Financial Officer and Executive Vice President of Actelion since 2013. Prior to this, he was the Chief Financial Officer of Pierre Fabre SA.
Nicholas Franco
Chief Business Development Officer; Executive Vice President Senior ManagementMr. Nicholas Franco has been the Chief Business Development Officer and Executive Vice President of Actelion since 2011. Prior to this, he was the Senior Vice President, International Commercial Operations at Axcan Pharma. Prior to that, Mr. Franco was Head of Market Access Region Europe for Novartis Pharma AG. He has over 20 years of pharmaceutical leadership experience in research, marketing, sales and business development across several therapeutic areas and geographies.
Alessandro Maresta
Head - Medical Affairs; Vice President Senior ManagementStill looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer